Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 400 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA2-mutated Metastatic Castration-Sensitive Prostate Cancer The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer MOST POPULAR What You Should Know About Receiving Online Medical Test Results and... September 6, 2022 Sparing the Hippocampus During PCI Better Preserves Cognitive Function in Patients... August 19, 2021 Food for thought: new insights into how chemotherapy causes cachexia June 15, 2022 Bride’s Escorted Down Aisle By Dad Of Organ Donor Who Saved... October 11, 2021 Load more HOT NEWS Changing the landscape of children’s cancer treatment Superior Prognostic Accuracy of Integrated 15-GEP/PRAME Classifier Over 15-GEP Alone in... Acing it: The ambitious early career researchers driving progress in cancer... A Daily Survival Kit for Serious Illness
